Controlling acute bacterial maxillary sinusitis

REFERENCES

• PITKANRA A, HAYDEN F: Rhinoviruses: important respiratory pathogens. Trends in clinical practice. The Finnish Medical Society Duodecim, Ann. Med. (1998) 30:529–537.
   Google Scholar
• WINTHER B, GWALTNEYJM JR: Acute and chronic sinusitis. In: Respiratory Infections: Diagnosis and Management 3rd edn. Pennington J (Ed.), Raven Press, New York, NY (1994) Ch. 7: 125–136.
   Google Scholar
• •Complete, expert review of the area (a chapter in a reference Book on 'Respiratory Infections' edited by James Pennington).
   Google Scholar
• REYNOLDS HY: Normal and defective respiratory host defenses. In: Respiratory Infections: Diagnosis and Management 3rd edn. Pennington J (Ed.), Raven Press, New York, NY (1994) Ch. 1: 1–34.
   Google Scholar
• KANKAM CG, SALLIS R: Acute sinusitis in adults. Difficult to diagnose, essential to treat. Postgrad. Med. (1997) 102:253–258.
   PubMed Web of Science ®Google Scholar
• •Practical, comprehensive, clearly written article, very useful for practitioners and ear, nose and throat specialists
   Google Scholar
• KLOSSEK JM, FERRIE JC: Radiology and pathologies of the paranasal cavities. Rev Laryngol. °to]. Rhino]. (1999) 120:167–172.
   PubMedGoogle Scholar
• LOW DE, DESROSIERS M, MCSHERRY J et al.: A practical guide for the diagnosis and treatment of acute sinusitis. Can. Med. Assoc. J. (1997) 156\(Suppl. 6):S1–514.
   Google Scholar
• ••This major publication is a practical guideto be used as a guideline for diagnosis and treatment of acute sinusitis. Includes all necessary recommendations in this field, based on consensus of Canadian and American experts.
   Google Scholar
• Recommandations AFSSAPS: Antibiothérapie par voie générale en pratique courante: sinusite aigu6 de l'adulte. Antibiotiques (2002) 2:127–129.
   Google Scholar
• WILLIAMS JW, SIMEL DL: Does this patient have sinusitis? Diagnosing acute sinusitis by history and physical examination. JAMA (1993) 270:1242–1246.
   PubMed Web of Science ®Google Scholar
• HUESTON WJ, EBERLEIN C, JOHNSON D, MAINOUS AG: Criteria used by clinicians to differentiate sinusitis from viral upper respiratory tract infection. Pam. Freer (1998) 46:487–492.
   Google Scholar
• •Interesting original article which establishes clearly the characteristics of viral versus bacterial sinus infection, based on a personal large experience (case-control study).
   Google Scholar
• SOKOL W: Epidemiology of sinusitis in the primary care setting: results from the 1999–2000 respiratory surveillance program. Am..! Med. (2001) 111\(Suppl. 94195–245.
   Google Scholar
• STOLL D, DUTKIEWICZ J, BOINEAU F, DUMON T: Bactériologie rhino-sinusienne. Rev. Laryngol °to]. Rhino]. (1996) 117:179–182.
   PubMedGoogle Scholar
• STOLL D: Inflammation rhinosinusienne aiguë. Presse Med. (2001) 30(39–40 Pt 2):33–40.
   Google Scholar
• •A comprehensive and complete analysis of the contribution in sinusitis of interactions between bacteria and immunological responses of the sinus mucosa.
   Google Scholar
• VAN CAUWENBERGE P, INGELS K: Effects of viral and bacterial infection on nasal and sinus mucosa. Acta Otolaryngol (1996) 116:316–321.
   PubMed Web of Science ®Google Scholar
• FELMINGHAM D, GRONEBERG RN: The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J. Antimicrob. Chemother (2000) 45(2):191–203.
   PubMed Web of Science ®Google Scholar
• •A publication by a classical well established group proceeding periodically to international surveys of resistance in major
   Google Scholar
• •• respiratory pathogens, useful for adaptation of empirical antibiotic therapy.
   Google Scholar
• PENTTILA M, SAVOLAINEN S, KIUKAANNIEMI H, FORSBLOM B, JOUSIMIES-SOMEER H: Bacterial findings in acute maxillary sinusitis - European study. Acta Otolaryngol Sapp] (1997) 529:165–168.
   PubMedGoogle Scholar
• BAX R, BYWATER R, CORNAGLIA G et al.: Surveillance of antimicrobial resistance - what, how and whither? Clin. Microbiol Infect. (2001) 7:316–325.
   Google Scholar
• MASTERTON RG: Surveillance studies:how can they help the management of infection?' Antimicrob. Chemother: (2000) 46(Suppl T2):53–58.
   Google Scholar
• BERGOGNE-BEREZIN E, VALUE E: Pharmacokinetics of antibiotics in respiratory tissues and fluids. In: Respiratory Infections. Diagnosis and Management; 3rd edn. Pennington JE (Ed.), Raven Press, New York, NY (1994) Ch. 35: 366–387.
   Google Scholar
• •A comprehensive review providing pharmacological bases (respiratory tissue distribution of antibiotics) of antibiotic therapy in respiratory infections.
   Google Scholar
• DINIS PB, MONTEIRO MC, MARTINS ML, SILVA N, GOMES A: Sinus tissue pharmacokinetics after oral administration of amoxicillin/clavulanic acid. Laryngoscope (2000) 110:1050–1054.
   PubMed Web of Science ®Google Scholar
• BERGOGNE-BEREZIN E: Tissue distribution of macrolide antibiotics. In: Bryskier AJ, Butzler JP, Neu HC, Tulkens PM (Eds), Macrolides. Chemistry Pharmacology and clinical uses. Arnette Blackwell Publishers, Paris (1993) Ch. 33: 451–484.
   Google Scholar
• OGAWA H, FUJISAWA T, KAZUYAMA Y: Isolation of Chlamydia pneumoniae from middle ear aspirates of otitis media with effusion: a case report. J. Infect. Dis. (1990) 162:1000–1001.
   PubMed Web of Science ®Google Scholar
• LISTER PD, SANDERS CC: Pharmacodynamics of levofloxacin and ciprofloxacin. Clin. Microb. Infect. (1998) 4:264–269.
   Google Scholar
• •New pharmacological approaches (pharmacodynarnics) of antibiotic therapy, particularly interesting in using fluoroquinolones.
   Google Scholar
• VALUE E, AZOULAY-DUPUIS E, POCIDALO JJ, BERGOGNE-BEREZIN E: Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection. Antimicrob. Agents Chemother: (1992) 36:1412–1417.
   PubMed Web of Science ®Google Scholar
• MURBACH V, BRONNER S, LINGER L et al.: Bêta-lactamases et inhibiteurs: existence dun effet post-inhibiteur de beta-lactamases de l'acide clavulanique sur H influenzae, K. pneumoniae et E. coli Antibiotiques (2001) 3:35–41.
   Google Scholar
• •Same approach as reference 22 as adapted to beta-lactams and beta-lactamase inhibitors.
   Google Scholar
• BRONNER S, POMPEI D, ELKHAILI H, DHOYEN N, MONTEIL H,JEHL F: Ex vivo 12h bactericidal activity of oral co-amoxiclav (1.125g) against I3-lactamase producing Haemophilus influenzae. Antimicrob. Chemother. (2001) 48:501–506.
   Google Scholar
• DRUSANO GL, CRAIG WA: Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. Chemother: (1997) 9:38–44.
   Web of Science ®Google Scholar
• •New pharmacological approaches (pharmacodynarnics) of antibiotic therapy, particularly interesting in using azithromycin.
   Google Scholar
• DE BOCK GH, DEKKER FW, STOLK J, SPRINGER MP, KIEVIT J, VAN HOUWELINGEN JC: Antimicrobial treament in acute maxillary sinusitis: a meta-analysis. Clin. Epidemiol (1997) 50:881–890.
   PubMed Web of Science ®Google Scholar
• ••A major article based on a large meta-analysis of antibiotic treatments in acute maxillary sinusitis, establishing data collected since the early 1980s, showing relatively limited and rare differences of efficacy between various antibiotic regimens.
   Google Scholar
• LINDBEAK M, HORTJDAHL P, JONHSEN UL: Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. Br. Med.' (1996) 313:325–329.
   PubMed Web of Science ®Google Scholar
• VAN BUCHEM FL, KNOTTNERUS JA, SCHRINEMAEKERS VJJ, PEETERS MF: Primary-care based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet (1997) 349:683–687.
   PubMed Web of Science ®Google Scholar
• FAGNAN, LJ: Acute sinusitis: a cost-effective approach to diagnosis and treatment. Am. Fam. Physician, (1998) 58:1795–1802.
   PubMed Web of Science ®Google Scholar
• BERT F, LAMBERT-ZECHOVSKY N: Microbiology of nosocomial sinusitis in intensive care unit patients. Infect. (1995) 31:5–8.
   Web of Science ®Google Scholar
• •An interesting original article reporting a study of bacterial flora in nosocomial sinusitis and the incidence of this infection as a function of type of ICU.
   Google Scholar
• BARZA M: Pharmacokinetics and efficacy of the new quinolones in infections of the eye, ear, nose and throat. Rev Infect. Dis. (1988) 10\(Supp1.1):S241–S247.
   Google Scholar
• BRYSKIER A: Les alternatives thérapeutiques dans les infections respiratoires: place de la lévofloxacine. Antibiotiques (2000) 2:35–51.
   Google Scholar
• SYDNOR TA, KOPP EJ, ANTHONY KE, LOCOCO JM, KIM SS, FOWLER CL: Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults. Ann. Allergy Asthma Immunol (1998) 80:357–362.
   PubMed Web of Science ®Google Scholar
• ADELGLASS J, DEABATE CA, MCELVAINE P, FOWLER CL, LOCOCCO J, CAMPBELL T: Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults. Otolaryngol Head Neck Surg. (1999) 120:320–327.
   PubMed Web of Science ®Google Scholar
• LASKO B, LAU CY, SAINT-PIERRE, REDDINGTON JL, MARTEL A ANSTEY RJ: Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. Irk. Med. Res. (1998) 26(6):281–291.
   Google Scholar
• ••Demonstrates the advantage of once-dailydosing, shorter duration of therapy and better tolerance of the fluoroquinolone.
   Google Scholar
• TILLOTSON GS, WATSON SJ: Moxifloxacin: from A (Antimicrobial) to Z (zwitterion) - a new 8-methoxyquinolone. Antibiotiques (2000) 2:185–194.
   Google Scholar
• BAZ MN, JANNETTI W, VILLANUEVA C et al: The efficacy and tolerabilty of mwdfloxacin compared to trovafloxacin in the treatment of acute sinusitis. Today's Therap. Trends (1999) 17:303–319.
   Google Scholar
• KLOSSEK J: Mwdfloxacin versus trovafloxacin in the treatment of acute sinusitis. 3rd European Congress on Chemotherapy Madrid, Spain (7–10 May 2000) Abstract M178.
   Google Scholar
• PERRY CM, ORMROD D, HURST M, ONRUST SV: Gatifloxacin: a review of its use in the management of bacterial infections. Drugs (2002) 62:169–207.
   PubMed Web of Science ®Google Scholar
• BERGOGNE-BEREZIN E: Resistance and new strategies. The other new molecules. Presse Med. (2000) 37:240–245
   Google Scholar
• BARMAN BALFOUR JA, FIGGITT DP: Tefithromycin. Drugs (2001) 61:815–831.
   PubMed Web of Science ®Google Scholar
• •A review of the characteristics and potential use in upper respiratory tract infections of a new antibacterial agent belonging to ketolides, a new antibiotic class. This drug, telithromycin is active against Gram-positive organisms, resistant to macrolides.
   Google Scholar
• ROOR K, BRUNSWIG-PATSCHNER C et al.: Efficacy and tolerability of a new ketofide antimicrobial, telithromycin (HMR 3647) for treatment of acute sinusitis. 40th ICAAC. Toronto, Canada (16 — 20 September 2000) Abstract 2243.
   Google Scholar
• GUAY DR: Review of ceftidoren, an advanced-generation, broad spectrum oral cephalosporin. Clin. Ther: (2001) 23:1924–1937.
   Google Scholar